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ABSTRACT
Background: To assess progress towards universal
health coverage, countries like Cambodia require
evidence on equity in the financing and distribution of
healthcare benefits. This evidence must be based on a
system-wide perspective that recognises the complex
roles played by the public and private sectors in many
contemporary healthcare systems.
Objective: To undertake a system-wide assessment of
who pays and who benefits from healthcare in
Cambodia and to understand the factors influencing
this.
Methods: Financing and benefit incidence analysis
will be used to calculate the financing burden and
distribution of healthcare benefits across
socioeconomic groups. Data on healthcare usage,
living standards and self-assessed health status will be
derived from a cross-sectional household survey
designed for this study involving a random sample of
5000 households. This will be supplemented by
secondary data from the Cambodian National Health
Accounts 2014 and the Cambodian Socioeconomic
Survey (CSES) 2014. We will also collect qualitative
data through focus group discussions and in-depth
interviews to inform the interpretation of the
quantitative analyses.
Potential impact: This study will produce previously
unavailable information on who pays for, and who
benefits from, health services across the entire health
system of Cambodia. This evidence comes at a critical
juncture in healthcare reform in South-East Asia with
so many countries seeking guidance on the equity
impact of their current financing arrangements that
include a complex mix of public and private providers.
INTRODUCTION
Universal health coverage (UHC), which
implies that all people have access to needed
services without the risk of ﬁnancial ruin, has
become a major goal for health reform in
many countries.1–3 The World Health Report
2010 on universal coverage of healthcare,
and the associated declaration of the World
Health Assembly, urged member states to
‘aim for affordable universal coverage and
access for all citizens on the basis of equity
and solidarity’.4 5 The way health systems are
ﬁnanced is a critical determinant for reach-
ing universal coverage.2 A health ﬁnancing
system is often divided conceptually into
three inter-related functions: revenue gener-
ation, pooling of resources and purchasing
of interventions.6 Revenue generation is con-
cerned with the raising of funds either dir-
ectly from users of healthcare or indirectly
through governments or donors. Pooling is
the accumulation and management of reven-
ues in ways that ensure that the risk of paying
for healthcare is borne by all the members of
the pool and not by each contributor indi-
vidually. Purchasing is the process of allocat-
ing funds to providers of healthcare.6 Equity
in health ﬁnancing refers to the distribution
of the burden of paying for healthcare
according to the ability to pay and the bene-
ﬁts from health spending on the basis of
need.2
Many low-income and middle-income
countries (LMICs), including Cambodia, are
currently seeking to reform their health
ﬁnancing systems so they can move quickly
to UHC and to sustain it once it has been
achieved.5–8 Cambodia’s Second Health
Sector Strategic Plan 2008–2015 sought to
put in place ﬁnancing reforms designed ‘to
enhance sustainable development of the
health sector for better health and well-being
of all Cambodians, especially of the poor,
women and children, thereby contributing to
poverty alleviation and socioeconomic devel-
opment’.9 These reforms are being pursued
against a backdrop of widespread poverty.10
Cambodia is one of the poorest countries in
the Asia Paciﬁc region with about 2 out of
every 10 Cambodians living below the
national poverty line; and rates of healthcare
use are among the lowest in the region.11
The country is characterised by a highly frag-
mented health system with a dominant and
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growing private sector.11 While government expenditure
on health has recently increased, it remains low at just
1.4% of gross domestic product (GDP) and total health
expenditure is 7% of GDP.12 In contrast, out-of-pocket
health expenditure by households is high with such
spending as a proportion of household budget at
around 5% and as a proportion of total health expend-
iture at 6%, some of the highest rates in Asia.13 14 These
expenses are mainly accrued in the private-for-proﬁt
sector, which is the main source of healthcare. Despite
the growing scale and importance of the private or non-
state sector across most LMICs, few attempts have been
made to integrate public and private sectors into assess-
ments of equity in healthcare payment and service use.2
Cambodia is currently exploring new ﬁnancing
mechanisms designed to promote access to effective and
affordable healthcare for its population, especially the
poor.10 12 These include internal contracting and a gov-
ernment midwifery incentive scheme to boost facility
deliveries, voluntary health insurance schemes targeting
the informal sector as well as a range of voucher schemes
designed to increase the uptake of reproductive and safe
motherhood services by poor rural communities.15–18
From a ﬁnancing perspective, Cambodia is perhaps best
known for its innovative Health Equity Funds (HEF), a
third party payer mechanism that reimburses public facil-
ities for health services rendered to the poor. Although
the initiative has now been expanded to cover ∼3.2
million poor, results until now have been mixed.14 19–21
The 2014 Demographic and Health Survey found that
only 9.3% of men and 13.1% of women in rural areas
had their health services paid for by a HEF.14 Another
review found that HEFs considerably reduced
out-of-pocket payments for health but had no impact on
care seeking and borrowing to pay for healthcare.21 The
most recent review by Annear and colleagues found that
more than 20% of all services measured at referral hospi-
tals are supported by a HEF and ∼20% for services at
health centres (HCs), leading the authors to conclude
that HEF members (the poor) access services at hospitals
at a greater proportion relative to their population size,
and at approximately the same proportion at HCs.19
Evaluations of individual ﬁnancing schemes such as HEFs
are valuable but do not replace the need for evidence on
the equity of healthcare spending and service use for the
health system as a whole.2
As Cambodia forges its path to universal coverage and
while debate grows on the relative merits of different
ﬁnancing schemes, it is crucial that evidence on equity in
health systems ﬁnancing is made available. This project
will undertake a ‘whole-of-system’ assessment of who pays
and who beneﬁts from healthcare in Cambodia that
incorporates Cambodia’s thriving private sector.
Research objectives and questions
The primary objective of this 3-year study (March
2015 to March 2018) is to evaluate equity in healthcare
payment and service use in Cambodia to support
progress towards UHC. Lessons from this study will be
relevant to a number of countries in the region that
have similar health ﬁnancing systems such as Vietnam,
Laos and Myanmar. Speciﬁc study questions include:
1. How is the burden of healthcare payments distribu-
ted across socioeconomic groups in Cambodia?
2. How are the beneﬁts from the health ﬁnancing
system (measured in terms of healthcare use) distrib-
uted across socioeconomic groups and according to
level of need?
3. What are the complex range of determinants of
healthcare usage and household spending on health
services in Cambodia?
METHODS
Theoretical framework
A conceptual framework can be useful in understand-
ing how a health ﬁnancing system is currently organised
and for assessing the equity impact of ﬁnancing
reforms.7 22 23
Frameworks like the one shown in ﬁgure 1 have been
proposed for analysing the performance of health
ﬁnancing systems and depict health ﬁnancing in terms
of the broad functions of collecting revenue, pooling
resources, and purchasing goods and services.23 The
framework shows that these functions often involve
complex interactions among a range of players in the
health sector. This conceptual framework is intended
as a starting point and it is our aim to use this as a basis
for developing a more insightful framework for the
Cambodia setting that reﬂects the multidimensional
array of institutional and organisational arrangements in
the local country context. The framework will also
enable a more precise characterisation of public and
private roles in healthcare ﬁnancing, something widely
acknowledged but, as previously mentioned, not well
understood.2
Study setting
This study assesses equity in healthcare use and spend-
ing across the entire healthcare system of Cambodia
which serves an estimated population of 15.8 million.24
Around 80% of the population live in rural areas, prac-
tising traditional wet rice cultivation and other forms of
agriculture, often at a subsistence level.25 The Khmer
make up 90% of the population while the remaining
10% includes Vietnamese, Chinese, Cham-Malay and
other diverse ethnic minority groups.25 While the
Ministry of Health has overall responsibility for the
health sector, the Cambodian health market has a wide
variety of public and private healthcare providers.12 26
The main provider of primary healthcare in Cambodia
is the private sector with only one in three patients
visiting the public sector for outpatient care.26
Two-thirds of public health staff also work privately.12
Non-governmental organisation health facilities and
charitable hospitals also provide services. Qualiﬁed
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private providers and pharmacies are most common in
urban areas. Non-medical health providers such as trad-
itional healers and drug peddlers are an important
source of care and can be found throughout the
country selling drugs from shops, markets or through
home visits.12 Government funding supports most of the
health infrastructure and stafﬁng in the community, and
delivers a subsidised, standard package of preventive,
primary and curative care.12 Revenues at government
facilities are supplemented by user charges introduced
in 1996, with exemptions provided to the poor.
Government health services are ﬁnanced from general
revenues, supported by donor funding.12 Currently,
there is no compulsory health insurance or social health
insurance coverage.
Study phases and design
The research questions will be addressed using a mix of
quantitative and qualitative methods. The quantitative
methods include the analysis of secondary data from the
latest national surveys and primary data from a cross-
sectional household survey. Qualitative methods com-
prise in-depth interviews and focus group discussions.
The project consists of three phases:
1. Quantitative assessment of equity in health care
payment and service use;
2. Qualitative investigation of factors inﬂuencing equity
in healthcare delivery and payments, paying
particular attention to the role of the private sector
(vis-à-vis the public sector); and
3. Integration and dissemination of ﬁndings from
phases 1 and 2.
Phase 1: measuring equity in healthcare delivery and
payments
This component of the study uses ﬁnancing incidence
analysis (FIA) and beneﬁt incidence analysis (BIA),
internationally accepted methods for the evaluation of
equity in health systems ﬁnancing, to measure the
extent to which healthcare payments are related to
ability to pay (ATP) and the use of healthcare is related
to need.2 27–30
Data sources and sampling
A combination of secondary and primary data is
required for the incidence analyses. For the FIA, the
Cambodian National Health Accounts (NHA) 201431
and the Cambodian Socioeconomic Survey (CSES)
201432 will be used to estimate the healthcare spending
mix and private/household payments to health through
direct and indirect taxation, out-of-pocket payments (eg,
for healthcare and medication) and any insurance con-
tributions. Tax thresholds and actual revenue from each
tax source will be those reported by the Ministry of
Finance.33 A key challenge of using existing national
household survey data sets such as the CSES is that
households may under-report their income, making it
Figure 1 Flow chart of the study selection process.
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difﬁcult to estimate their tax contributions. To overcome
these challenges, we intend to triangulate the revenues
estimated from the survey data with actual revenue esti-
mates obtained from the appropriate national
authorities.28
For the BIA, unit cost data for the different health ser-
vices will be derived from a recent hospital and HC
costing study conducted by the Cambodian Ministry of
Health.34 The BIA also requires healthcare usage data
on every episode of care that is ideally disaggregated by
level of care (eg, outpatient/inpatient) and by type of
public and private facility (eg, HC, public hospital,
private hospital, etc).29 Existing data sets in Cambodia
such as the Health Management Information System do
not provide this type of detailed usage information,
making it necessary for this study to undertake a cross-
sectional household survey.
The Cambodian Health Equity and Financing (CHEF)
household survey will involve the random selection of
5000 households across Cambodia, with 2000 house-
holds from urban areas and 3000 others from rural
areas. This sample size will enable us to determine
prevalence for characteristics with a 95% CI with a preci-
sion of ±3%. It will also allow us, with at least 80% power
and a signiﬁcance level of 5%, to be able to detect dif-
ferences of 5% for comparisons between urban and
rural areas. In each selected household, one woman
(the primary caregiver) or, in her absence, the male
head will be interviewed. The interviews will be guided
by a structured e-questionnaire, which covers key areas
including living standard measures, demographic and
socioeconomic data, health service use, satisfaction rat-
ing, quality of care and healthcare payments. Electronic
data collection involving the use of laptops by enumera-
tors will be used. The e-questionnaire will be designed
using the NOVA Research Company’s Questionnaire
Development System (QDS) V.3.0 and administered with
the computer-assisted personal interview program.
A questionnaire previously used by this team in other
Asia-Paciﬁc countries will be adapted for use in
Cambodia.35 The questionnaire will be piloted among
households from different socioeconomic backgrounds.
Enumerators will undertake a 3-day training session in
procedures for the household survey and be monitored
by experienced supervisors in the ﬁeld. The question-
naire and all related training materials will be made
available here: https://sphcm.med.unsw.edu.au/project/
system-wide-analysis-health-ﬁnancing-equity-cambodia.
Socioeconomic information, to enable the ranking of
households by their living standards and for the assess-
ment of ATP for healthcare, will be collected in the
CHEF household survey.
Financing incidence analysis
FIA, also known as progressivity analysis, compares the
distribution of the burden of healthcare payments with
the distribution of overall economic resources. A health
ﬁnancing system is deemed progressive (regressive)
relative to ATP if the rich contribute a relatively higher
(lower) proportion of their income to healthcare ﬁnan-
cing than the poor. Payments to healthcare ﬁnancing in
Cambodia are primarily through taxes, direct out-
of-pocket payments, donor funding and voluntary health
insurance. Taxes considered in this study include direct
taxes (personal income tax and corporate tax) and
indirect taxes (value added taxes, custom duty and with-
holding tax).
FIA comprises two stages of computation: (1) the pro-
gressivity of each type of healthcare payment; and (2)
the overall progressivity of the healthcare system. To cal-
culate the progressivity of each payment mechanism,
payments made by households will be estimated as a
percentage of total household expenditure and then tri-
angulated with actual revenue for each revenue source
from the Cambodian Ministry of Economy and Finance.
Progressivity of the health system as a whole is calculated
by weighting the progressivity of the different health
ﬁnancing sources by their relative contribution to total
health funding.2 28
Progressivity of healthcare spending will be illustrated
using the Lorenz and concentration curves. 28 33 The
Lorenz curve is a graphical representation of the cumu-
lative distribution of ATP while the concentration curve
plots the cumulative distribution of healthcare payments.
The concentration index is twice the area between the
concentration curve and line of equality. The concentra-
tion index ranges from −1.0 (entire ﬁnancial burden is
concentrated in the hands of the poorest person) to
+1.0 (entire ﬁnancial burden is concentrated in the
hands of the richest person).
The relative progressivity of each source of healthcare
revenue will also be assessed using the Kakwani index,36
a measure of inequality widely used in public ﬁnance
including the assessment of equity in health systems
ﬁnancing.2 28 33 37 38 The Kakwani index, deﬁned as
twice the area between the concentration curve of
health payments and the Lorenz curve, will be calcu-
lated as follows:
pK¼ C G ð1Þ
Where C is the health payment concentration index and
G is the Gini coefﬁcient of household income or
expenditure. The value of the Kakwani index (πK)
ranges from −2.0 to +1.0. A negative index value indi-
cates that healthcare payments are pro-rich (regressive)
and that the concentration curve lies inside the Lorenz
curve. In contrast, a positive value indicates the progres-
sivity, and its concentration curve lies outside the Lorenz
curve. To calculate overall progressivity of the health
system, a weighted average of the Kakwani indices of the
individual payment mechanisms will be derived, where
the weights are the shares of total revenues coming from
each source.
The construction of the ATP or socioeconomic
measure in this study will be based on reported
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household consumption expenditures including food,
housing and other household expenditures derived from
the CSES data set. This measure, which has been applied
in similar studies,2 39–42 also takes into consideration
consumption from sources other than purchases from
the market (eg, subsistence agriculture products).
Consumption expenditure is generally recognised as
being more stable, reliable and easier to obtain than
income.40 The pros and cons of different measures of
ATP are discussed in detail elsewhere.40
Household estimates of aggregate expenditure will be
adjusted to reﬂect household size and composition.2 27
Per adult equivalent household consumption will be cal-
culated using the formula:
AEi¼(Ai + aK)u ð2Þ
Where A is the number of adults in the household, K
is the number of children (0–14), α is the ‘cost of chil-
dren’ (given a value of 0.5 in this study) and θ deter-
mines the degree of economies of scale.39 The
population will then be ranked by socioeconomic status
and grouped into quintiles of equal size.
Tests of dominance will be performed to ascertain
which payment mechanism is statistically progressive or
regressive.43 A multiple comparison approach and 19
comparison points at 5% signiﬁcance level will be used
for the dominance tests as proposed by O’Donnell
et al.44 Sensitivity analysis will be used to assess how the
results of the FIA differ under different assumptions and
test whether any difference is statistically signiﬁcant.44
For example, household income from the 2014 CSES
will be explored as an alternative measure of socio-
economic status in the sensitivity analysis. Analyses will
be performed using the Stata Statistical Software
Package and the World Bank’s ADePT Software Platform
for Automated Economic Analysis.45
Benefit incidence analysis
BIA will be used to assess the distribution of healthcare
beneﬁts for public and private providers across socio-
economic groups and according to need for care.
Speciﬁcally, we will analyse beneﬁt incidence for
inpatient, outpatient and preventive healthcare by level
of care (ie, primary, hospital and referral level) and own-
ership of facilities (public, private for-proﬁt, faith-
based). We will use self-assessed health as a measure of
need.27 28 40 42
Usage rates for each category of health service will be
multiplied by the unit cost of that service to estimate
monetary beneﬁts.27 For the government subsidy,
out-of-pocket payments by service users will be sub-
tracted from total beneﬁts.27 To ascertain whether a
beneﬁt distribution for a given provider is pro-rich or
pro-poor, we will construct bar charts indicating the rela-
tive share of total beneﬁts received by each quintile. If
the poorest members of the population receive a higher
share of healthcare beneﬁts compared with the rich, the
system is deemed pro-poor.28 Further, we will compare
the distribution of beneﬁts, depicted by the concentra-
tion curve, against the 45° line of perfect equality. If the
concentration curve lies above (below) the 45° line, the
distribution is pro-poor (pro-rich).
Mathematically, beneﬁt incidence is estimated by the
following formula:
Xj¼aiUij(Si=Ui)¼ai(Uij=Ui)Si¼aieijSi ð3Þ
where j=sector-speciﬁc subsidy enjoyed by group j;
Uij=usage of service i by group j; Ui=usage of service i by
all groups combined; Si=government net expenditure
on service i; and e ij=group j’s share of usage of service
I.46
Equity implies that healthcare beneﬁts are distributed
according to healthcare need.29 Within the CHEF
household survey, the household head will be asked to
rank their health status on a scale of 1 to 3: good (rarely
gets ill), fair (occasionally gets ill), bad (chronically
and/or frequently ill). Those who ranked themselves to
be either in poor or very poor health are considered to
be in higher need of healthcare.
The sensitivity of the BIA results will be tested under
three different assumptions: the constant unit cost assump-
tion, which treats the sum of individual fees and govern-
ment subsidies as constant; the constant unit subsidy
assumption, which allocates the same subsidy to each unit
of service used irrespective of the fees paid; and the pro-
portional unit cost assumption, which makes the cost of
care proportional to the fees paid.47 As for the FIA, ana-
lyses will be performed using the Stata Statistical
Software Package and the World Bank’s ADePT
Software.45
The quality of health services and its impact on bene-
ﬁts received will also be explored in this study. Generally,
quality services are based on evidence of what interven-
tions are most effective and are provided in a technically
competent way.6 It also extends to professional and
empathic interpersonal engagements between providers
and patients.6 Information on quality variation will be
gathered in this study through focus group discussions
with users and healthcare providers (see ‘phase 2’
below). These results will be reported separately to com-
plement the quantitative results. In addition, we will
seek to develop ‘weightings’ to be applied to health ser-
vices in different districts (ie, rural and urban) to
reﬂect, for example, how well staffed they are.48 Data
required to develop such weightings will be obtained
from secondary sources including the Health Sector
Strategic Plan 2008–2015.9 This would be a ﬁrst step in
recognising variation in the quality of health services
provided to different groups of users.
Phase 2: factors influencing equity in the delivery and
payment of healthcare
Qualitative methods can be a powerful tool to aid under-
standing, provide explanations and explore in-depth the
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complexity of socioeconomic variables and perceptions
underlying ﬁndings from quantitative surveys in health
economics.49 50 Qualitative methods have, for example,
been used alongside ﬁnancing and beneﬁt incidence
analyses to explore the factors that inﬂuence the burden
of healthcare spending and distribution of healthcare
beneﬁts/use.49 Such methods have also been applied to
understand the factors inﬂuencing the implementation
of different ﬁnancing reforms including community
health insurance schemes, vouchers and HEFs in
Cambodia and other LMICs.18 51 52 For this study, topics
that have strategic importance for equity, economic
burden and distribution of beneﬁts across socio-
economic groups will be selected after review of the
quantitative ﬁndings and the identiﬁcation of gaps in
the literature on healthcare ﬁnancing in Cambodia. The
key domains for qualitative analysis are likely to include
access within the community to information about
health services and entitlements, including insurance
schemes and user fee exemptions for the poor; patients’
perceptions about the quality of public and private
health services; physical access to health providers
including access to preventive care and travelling time;
the costs of seeking healthcare; economic behaviour and
borrowing practices of patients and their families; and
the availability of private services inside and outside the
country. These domains will be considered across the
spectrum of Cambodian society, from the rich and
middle class to the most vulnerable population groups.
Data sources and sampling
IDIs will be conducted with two categories of partici-
pants: (1) community/household members and (2) key
informants who can discuss relevant health service and
policy issues such as policymakers, health professionals,
senior staff at local non-government organisations and
international organisations. Participants at the house-
hold level will be selected across socioeconomic groups
as identiﬁed in the quantitative component of the study
(eg, urban middle class, urban poor, rural populations).
Sampling will continue until data saturation is achieved
but it is estimated that 15–20 IDIs will be required per
population group. Interviews will be conducted in
Khmer, taped and subsequently translated into English.
Given that decisions about health service usage and
spending are made in a ‘social context’, a series of FGDs
will also be conducted. Approximately 20 FGDs will be
conducted at the community level and will be segmen-
ted by location (rural/urban) and by gender (male/
female) to encourage effective and open discussion.
Each FGD will have about 6–8 adult household
members who have not already participated in an IDI.
Different approaches such as the use of warm-up ques-
tions, a non-threatening environment and a clear
explanation of the goals of the discussion will be used to
build trust in the moderator and the process. Two local
facilitators and four interviewers who speak Khmer will
be trained by an experienced qualitative researcher
(ML) to support the FGDs and IDIs. The qualitative
data will be coded and analysed using a thematic
content analysis approach based on a framework devel-
oped through an iterative process to harness the full
explanatory and interpretive potential of the qualitative
data set.53 54 Short summaries of the IDIs and FGDs will
be compiled and emerging themes will be used to guide
data coding, using QSR NVivo V.11. Independent coding
will be carried out by the research team and codes will
be repeatedly reviewed for validation and reliability, and
compared with the initial data summaries.
Phase 3: merging and interpretation of results
The qualitative and quantitative strands of the study will
ﬁrst be interpreted and presented separately. Then they
will be merged to provide a more complete understand-
ing of equity in health systems ﬁnancing, with particular
attention to potential challenges (and opportunities)
that may result from divergences in theoretical founda-
tions, methods, generalisability and presentational
norms across disciplinary perspectives.55 After careful
evaluations of these issues, different integration methods
will be developed and used to promote understanding
across different target audiences (see ‘target audiences
and involvement strategies’ section below). These may
include narratives where qualitative and quantitative
ﬁndings are described together in a report on a
theme-by-theme basis and joint displays for organising
the related data in ﬁgures, tables and graphs.55 56 Where
appropriate, the qualitative results will also be mapped
to the ﬁndings from the ﬁnancing and beneﬁt incidence
analyses—for example, if the BIA were to reveal a pro-
rich distribution of beneﬁts resulting from limited access
to higher level facilities among poor and rural popula-
tions, then this would be complemented by qualitative
information on the different types of barriers in acces-
sing healthcare and their relative importance from a
consumer and provider perspective.
Data management and quality assurance
All research materials and data from this study will be
held and preserved in accordance with the University of
New South Wales’ (UNSW) Research Data management
guidelines: http://www.gs. unsw.edu.au/policy/ docu-
ments/researchdataproc.pdf. Quality assurance proce-
dures will be built into the data management system and
implemented alongside other data management activities
to ensure timely detection and resolution of errors in the
data. A central project database that is password pro-
tected will be established using the UNSW research data
portal. This will be the ultimate home of the data and will
be established in advance of data collection. Access to the
database will be given only to members of the study team.
The use of the e-data collection method means that data
can be transferred directly from the ﬁeld to the project
central database immediately after collection. There will
be a dedicated staff member to receive all data and
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prepare it for analysis. The data will be archived using the
UNSW long-term data archiving system.
Target audiences and involvement strategies
This study will involve policymakers through local work-
shops and other means using locally appropriate
approaches including targeting annual health review
and strategic health planning meetings. The approach
taken can be characterised as evidence of co-production
—a process of conducting research in collaboration with
its end users. This approach has been shown to promote
research ﬁndings that are relevant to decision makers
and more likely to be taken up in practice.57–59 Two
team members are situated in the Department of
Planning and Health Information that houses the
Bureau of Health Financing in the Cambodian Ministry
of Health and will be in an ideal position to feed the
results of this project into key decision-making processes.
To reach academic audiences, results will be published in
relevant scholarly journals and presented to appropriate
national, regional and international audiences, policy-
makers and stakeholders at high-proﬁle international
meetings including the Global Symposium on Health
Systems Research and the annual International Health
Economics Association Congress. Results and tools
(surveys and training materials) arising from this project
will be shared with students trained at each of the partici-
pating universities and other academic institutions in
the Asia-Paciﬁc region. These future health practitioners
will beneﬁt from the lessons of the project through
teaching material developed by members of this project.
Finally, information about this project will be dissemi-
nated to members of the public, researchers and study
stakeholders through an interactive website, podcasts
and webinars.
Ethical considerations
Ethical clearance for the quantitative component of the
study has been obtained from the National Ethics
Committee for Health Research in Cambodia (REF: 362
NECHR) and the University of New South Wales (REF:
HC1543). Ethical approval for the qualitative part of the
study will be sought once the quantitative component is
completed.
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